Sign inGet started

Yang Arvin

Insider CIK 1834321 · MRSN SVP, Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MRSN Mersana Therapeutics, Inc. S Sale2023-01-172023-01-182,209$5.74 $12.7K30,821SEC↗
MRSN Mersana Therapeutics, Inc. M Exercise deriv2023-01-142023-01-187,084— $021,249SEC↗
MRSN Mersana Therapeutics, Inc. M Exercise2023-01-142023-01-187,084— $033,030SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2023-01-132023-01-18217,500— $0217,500SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2023-01-132023-01-1848,333— $048,333SEC↗
MRSN Mersana Therapeutics, Inc. S Sale2022-12-012022-12-025,527$6.59 $36.4K25,946SEC↗
MRSN Mersana Therapeutics, Inc. M Exercise deriv2022-11-302022-12-0218,500— $00SEC↗
MRSN Mersana Therapeutics, Inc. M Exercise2022-11-302022-12-0218,500— $031,473SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2022-01-142022-01-19127,500— $0127,500SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2022-01-142022-01-1928,333— $028,333SEC↗
MRSN Mersana Therapeutics, Inc. S Sale2021-12-012021-12-025,527$6.81 $37.6K12,973SEC↗
MRSN Mersana Therapeutics, Inc. M Exercise deriv2021-11-302021-12-0218,500— $018,500SEC↗
MRSN Mersana Therapeutics, Inc. M Exercise2021-11-302021-12-0218,500— $018,500SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2020-11-302020-12-02200,000— $0200,000SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2020-11-302020-12-0237,000— $037,000SEC↗